3F8 monoclonal antibody treatment of patients with stage IV neuroblastoma: a phase Ii study
Cheung, N.K.; Kushner, B.H.; Yeh, S.J.; Larson, S.M.
Progress in Clinical and Biological Research 385: 319-328
1994
ISSN/ISBN: 0361-7742 PMID: 7972227 Document Number: 425890
Document emailed within 1 workday
Related Documents
Cahn, J.Y.; Bordigoni, P.; Tiberghien, P.; Milpied, N.; Brion, A.; Widjenes, J.; Lioure, B.; Michel, G.; Burdach, S.; Kolb, H.J. 1995: Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. a multicenter phase IIi study Transplantation 60(9): 939-942Bai, Y. 1989: Monoclonal antibody in the detection of neuroblastoma cells in bone marrow aspirates Zhonghua Zhong Liu Za Zhi 11(4): 260-262
Etoh, T. 1985: Analysis of tumor antigens and clinical applications of monoclonal antibody (A 2 B 5) for neuroblastoma Gan no Rinsho. Japan Journal of Cancer Clinics 31(3): 299-302
Duerst, R.E.; Ryan, D.H.; Frantz, C.N. 1986: Variables affecting the killing of cultured human neuroblastoma cells with monoclonal antibody and complement Cancer Research 46(7): 3420-3425
Berthold, F.; Schumacher, R.; Schneider, A.; Bosslet, K.; Reiter, C. 1989: Removal of neuroblastoma cells from bone marrow by a direct monoclonal antibody rosetting technique Bone Marrow Transplantation 4(3): 273-278
Saarinen, U.M.; Coccia, P.F.; Gerson, S.L.; Pelley, R.; Cheung, N.K. 1985: Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow Cancer Research 45(11 Pt 2): 5969-5975
Blottière, H.M.; Douillard, J.Y.; Koprowski, H.; Steplewski, Z. 1990: Immunoglobulin class and immunoglobulin G subclass analysis of human anti-mouse antibody response during monoclonal antibody treatment of cancer patients Cancer Research 50(3 Suppl): 1051s-1054s
Nishimoto, N.; Yoshizaki, K.; Maeda, K.; Kuritani, T.; Deguchi, H.; Sato, B.; Imai, N.; Suemura, M.; Kakehi, T.; Takagi, N.; Kishimoto, T. 2003: Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study Journal of Rheumatology 30(7): 1426-1435
Kovarik, J.; Zlabinger, G.J.; Wolfram, J.; Pecherstorfer, M.; Watschinger, B.; Traindl, O.; Pohanka, E.; Sonnleitner, A.; Ulrich, W. 1989: OKT3 monoclonal antibody treatment in renal transplant recipients--clinical experience in 49 patients Transplantation Proceedings 21(1 Part 2): 1748-1752
Daifuku, R.; Panacek, E.A.; Haenftling, K.; Swenson, W.K.; Prescott, A.W.; Johnson, J.L. 1993: Pilot study of anti-lipopolysaccharide human monoclonal antibody MAB-T88 in patients with gram-negative sepsis Human Antibodies and Hybridomas 4(1): 36-39
Jin, J.; Li, Y-Xiong.; Liu, Y-Ping.; Wang, W-Hu.; Li, T.; Li, N.; Song, Y-wen. 2006: Phase I study of postoperative concurrent chemoradiation with capecitabine as adjuvant treatment for stage II/III operable rectal cancer Zhonghua Zhong Liu Za Zhi 28(5): 393-396
Lewis, I.J.; Lashford, L.S.; Fielding, S.; Flower, M.A.; Ackery, D.; Kemshead, J. 1991: A phase I/Ii study of 131i mIBG in chemo-resistant neuroblastoma. the United Kingdom Children's Cancer Study Group (UKCCSG) Progress in Clinical and Biological Research 366: 463-469
Bernstein, I.D.; Evans, A.E.; Finklestein, J.; Klemperer, M.; Hittle, R.; Leikin, S.; Hammond, G.D. 1978: Phase II study of the failure of vincristine and bleomycin for previously treated children with metastatic neuroblastoma: a report from the Childrens Cancer Study Group Cancer Treatment Reports 62(8): 1201-1202
Ouaissi, M.A.; Taibi, A.; Loyens, M.; Martin, U.; Afchain, D.; Maidana, C.; Caudioti, C.; Cornette, J.; Martelleur, A.; Velge, P. 1991: Trypanosoma cruzi: a carbohydrate epitope defined by a monoclonal antibody as a possible marker of the acute phase of human Chagas' disease American Journal of Tropical Medicine and Hygiene 45(2): 214-225
Hancock, W.W.; Sablinski, T.; Milford, E.L.; Tilney, N.L.; Atkins, R.C.; Kupiec-Weglinski, J.W. 1990: Beneficial effects of monoclonal antibody targeting of CD4+ cells during the sensitisation but not effector phase of accelerated rejection of rat cardiac allografts Transplantation Proceedings 22(5): 2115-2116
Kargi, A.; Yalcin, A.D.; Erin, N.; Savas, B.; H. Hüseyin Polat; Gorczynski, R.M. 2012: IL8 and Serum Soluble Trail Levels Following Anti-VEGF Monoclonal Antibody Treatment in Patients With Metastatic Colon Cancer Clinical Laboratory 58(5-6): 501-505
Polak, A.; Franek, A.; Blaszczak, E.; Nawrat-Szoltysik, A.; Taradaj, J.; Wiercigroch, L.; Dolibog, P.; Stania, M.; Juras, G. 2014: A prospective, randomized, controlled, clinical study to evaluate the efficacy of high-frequency ultrasound in the treatment of Stage II and Stage III pressure ulcers in geriatric patients Ostomy/Wound Management 60(8): 16-28
Murray, J.L.; Macey, D.J.; Grant, E.J.; Rosenblum, M.G.; Kasi, L.P.; Zhang, H.Z.; Katz, R.L.; Riger, P.T.; LeBherz, D.; Bhadkamkar, V. 1995: Enhanced TAG-72 expression and tumor uptake of radiolabeled monoclonal antibody CC49 in metastatic breast cancer patients following alpha-interferon treatment Cancer Research 55(23 Suppl): 5925s-5928s
2016: Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Final Analysis of a Randomized Phase II Study Clinical Advances in Hematology and Oncology: H&o 14(2 Suppl. 1): 9-10
Gasparini, G.; Pozza, F.; Meli, S.; Reitano, M.; Santini, G.; Bevilacqua, P. 1991: Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness Anticancer Research 11(6): 2015-2021